Savara, Inc. (SVRA)
4.22
-0.32
(-7.05%)
USD |
NASDAQ |
Oct 23, 16:00
4.28
+0.06
(+1.42%)
After-Hours: 20:00
Savara Market Cap : 866.79M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 866.79M |
| October 22, 2026 | 932.51M |
| October 21, 2026 | 959.22M |
| October 20, 2026 | 977.70M |
| October 19, 2026 | 951.00M |
| October 16, 2026 | 914.03M |
| October 15, 2026 | 973.59M |
| October 14, 2026 | 977.70M |
| October 13, 2026 | 981.81M |
| October 12, 2026 | 994.13M |
| October 09, 2026 | 1.011B |
| October 08, 2026 | 992.08M |
| October 07, 2026 | 1.002B |
| October 06, 2026 | 955.11M |
| October 05, 2026 | 981.81M |
| October 02, 2026 | 987.97M |
| October 01, 2026 | 1.036B |
| September 30, 2026 | 1.060B |
| September 29, 2026 | 1.043B |
| September 28, 2026 | 1.041B |
| September 25, 2026 | 1.027B |
| September 24, 2026 | 1.041B |
| September 23, 2026 | 1.027B |
| September 22, 2026 | 1.089B |
| September 21, 2026 | 1.119B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.103B |
| September 17, 2026 | 1.113B |
| September 16, 2026 | 1.054B |
| September 15, 2026 | 1.080B |
| September 14, 2026 | 1.097B |
| September 11, 2026 | 1.089B |
| September 10, 2026 | 1.093B |
| September 09, 2026 | 1.112B |
| September 08, 2026 | 1.136B |
| September 04, 2026 | 1.103B |
| September 03, 2026 | 1.103B |
| September 02, 2026 | 1.121B |
| September 01, 2026 | 1.099B |
| August 31, 2026 | 1.107B |
| August 28, 2026 | 1.080B |
| August 27, 2026 | 1.128B |
| August 26, 2026 | 1.152B |
| August 25, 2026 | 1.150B |
| August 24, 2026 | 1.142B |
| August 21, 2026 | 1.148B |
| August 20, 2026 | 1.128B |
| August 19, 2026 | 1.146B |
| August 18, 2026 | 1.103B |
| August 17, 2026 | 1.103B |
| August 14, 2026 | 1.105B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 193.65B |
| Insmed, Inc. | 20.39B |
| United Therapeutics Corp. | 25.07B |
| Vertex Pharmaceuticals, Inc. | 132.74B |
| ACADIA Pharmaceuticals, Inc. | 3.396B |
Market Cap Related Metrics
| PEG Ratio | -0.5903 |
| Price to Book Value | 6.034 |
| Price | 4.22 |
| Earnings Yield | -13.66% |
| PEGY Ratio | -0.5903 |